Other languages Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
3.18 ^USD	+2.25%		+13.98%	-35.10%

May. 07	Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, vs. Street Est of $38.8M	MT
May. 07	Adaptive Biotechnologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adaptive Biotechnologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO	Apr. 02
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024	Apr. 02
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down	Feb. 15
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 14
Adaptive Biotechnologies Corporation and Collaborators to Present More Than 30 Abstracts Demonstrating the Actionability of ClonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th Annual Meeting	Dec. 05
Las mejores acciones para ganar en bolsa en Wall Street en 2024	Nov. 20
Adaptive Biotechnologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Adaptive Biotechnologies Corporation Updates Revenue Guidance for the Full Year 2023	Nov. 09
Adaptive Biotechnologies Partners With BeiGene on Minimal Residual Disease Testing of Potential Treatments for Lymphoid Malignancies	Nov. 07
Adaptive Biotechnologies Corporation Announces New Translational Collaboration to Measure Minimal Residual Disease with Clonoseq(R) Assay Across Beigene's Lymphoid Malignancy Pipeline	Nov. 07
Adaptive Biotechnologies Corporation Announces Launch of Epic Integration for ClonosEQ	23-09-13
Adaptive Biotechnologies Corporation Announces Kevin Conroy Resigns from the Board	23-09-01
Insider Sell: Adaptive Biotechnologies	23-08-08
Adaptive Biotechnologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02
Adaptive Biotechnologies Corporation Announces Executive Changes	23-08-02
Insider Sell: Adaptive Biotechnologies	23-06-21
Insider Sell: Adaptive Biotechnologies	23-06-20
Adaptive Biotechnologies Corporation Announces Resignation of Leslie Trigg from the Board	23-06-13
Insider Sell: Adaptive Biotechnologies	23-06-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Other languages

Filters